27/01/2021
As part of the EuropaBio National Associations Council, this meeting kick starts a long term Brexit monitoring Group within EuropaBio which will support members to understand […]
17/06/2020
The pharmaceutical and biotechnology industries are doing everything in their power to prepare for all scenarios and need the support of the European Union to ensure that we can fulfil our promise to the patients who we serve.
31/03/2018
The associations representing the European and British life science industry have today responded to the European Council approving terms of the transition period agreed between the UK Government and EU.
31/03/2018
The European Health Community has warned that time is running out to secure patients’ interests in Brexit negotiations. With Phase 2 of the negotiations looming, health groups across Europe have drawn up a list of crucial unanswered questions that must be answered by the EU and UK negotiators to ‘put patients first’ in the negotiations.
28/12/2017
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit the European Union.